Performance assessment of the Bruker Biotyper MALDI-TOF MS for the identification of difficult-to-identify viridans group streptococci
Differentiating Streptococcus pneumoniae among nonpneumococcal viridans group streptococci (VGS) is challenging in conventional laboratories. Therefore, we aimed to evaluate the performance of the latest Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) system in identifying VGS by comparing the results to those of the specific gene sequencing approach. Clinical isolates were initially identified using the BD Phoenix system to identify Streptococcus species. The optochin test was used to distinguish nonpneumococcal VGS from S. pneumoniae. The species of individual reference strains and clinical isolates were determined by comparing the sequences of the 16S rDNA, gyrB, sodA, groESL, or coaE genes with those in the GenBank sequence databases. We evaluated the performance of the Bruker Biotyper MALDI-TOF MS in VGS identification using two different machines with three databases. We collected a total of 103 nonpneumococcal VGS and 29 S. pneumoniae blood isolates at a medical center in northern Taiwan. Among these isolates, only seven could not be identified at the species level by the specific gene sequencing approach. We found that none of the nonpneumococcal VGS isolates were misidentified as pneumococci by the latest Biotyper system, and vice versa. However, certain strains, especially those in the mitis and bovis groups, could still not be correctly identified. The latest Bruker Biotyper 4.1 (DB_10833) showed significant improvement in identifying VGS strains. However, a specific gene sequencing test is still needed to precisely differentiate the species of strains in the mitis and bovis groups.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
---|---|
Enthalten in: |
Journal of clinical microbiology - 61(2023), 12 vom: 19. Dez., Seite e0114323 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wan, Tsai-Wen [VerfasserIn] |
---|
Links: |
---|
Themen: |
16S rDNA |
---|
Anmerkungen: |
Date Completed 20.12.2023 Date Revised 02.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1128/jcm.01143-23 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365295760 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365295760 | ||
003 | DE-627 | ||
005 | 20240202232054.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1128/jcm.01143-23 |2 doi | |
028 | 5 | 2 | |a pubmed24n1278.xml |
035 | |a (DE-627)NLM365295760 | ||
035 | |a (NLM)38038480 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wan, Tsai-Wen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Performance assessment of the Bruker Biotyper MALDI-TOF MS for the identification of difficult-to-identify viridans group streptococci |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.12.2023 | ||
500 | |a Date Revised 02.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Differentiating Streptococcus pneumoniae among nonpneumococcal viridans group streptococci (VGS) is challenging in conventional laboratories. Therefore, we aimed to evaluate the performance of the latest Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) system in identifying VGS by comparing the results to those of the specific gene sequencing approach. Clinical isolates were initially identified using the BD Phoenix system to identify Streptococcus species. The optochin test was used to distinguish nonpneumococcal VGS from S. pneumoniae. The species of individual reference strains and clinical isolates were determined by comparing the sequences of the 16S rDNA, gyrB, sodA, groESL, or coaE genes with those in the GenBank sequence databases. We evaluated the performance of the Bruker Biotyper MALDI-TOF MS in VGS identification using two different machines with three databases. We collected a total of 103 nonpneumococcal VGS and 29 S. pneumoniae blood isolates at a medical center in northern Taiwan. Among these isolates, only seven could not be identified at the species level by the specific gene sequencing approach. We found that none of the nonpneumococcal VGS isolates were misidentified as pneumococci by the latest Biotyper system, and vice versa. However, certain strains, especially those in the mitis and bovis groups, could still not be correctly identified. The latest Bruker Biotyper 4.1 (DB_10833) showed significant improvement in identifying VGS strains. However, a specific gene sequencing test is still needed to precisely differentiate the species of strains in the mitis and bovis groups | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a 16S rDNA | |
650 | 4 | |a MALDI-TOF MS | |
650 | 4 | |a Streptococcus pneumoniae | |
700 | 1 | |a Lee, Tai-Fen |e verfasserin |4 aut | |
700 | 1 | |a Chen, Xiang-Jun |e verfasserin |4 aut | |
700 | 1 | |a Hunag, Yun-Tsung |e verfasserin |4 aut | |
700 | 1 | |a Teng, Lee-Jene |e verfasserin |4 aut | |
700 | 1 | |a Hsueh, Po-Ren |e verfasserin |4 aut | |
700 | 1 | |a Chiu, Hao-Chieh |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical microbiology |d 1975 |g 61(2023), 12 vom: 19. Dez., Seite e0114323 |w (DE-627)NLM000005460 |x 1098-660X |7 nnns |
773 | 1 | 8 | |g volume:61 |g year:2023 |g number:12 |g day:19 |g month:12 |g pages:e0114323 |
856 | 4 | 0 | |u http://dx.doi.org/10.1128/jcm.01143-23 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 61 |j 2023 |e 12 |b 19 |c 12 |h e0114323 |